Identity
- Trade Name
- Lachrymal Cannulae FDA UDI
- Generic Name
- Lacrimal procedural cannula FDA UDI
- Device Name
- 21g x 1 1/2" Lachrymal FDA UDI
- Model / Reference
- 9274NS-02/Y FDA UDI
- Description
- 21g x 1 1/2" Lachrymal FDA UDI
Identifiers
- Catalog Number
- M9274 FDA UDI
- Primary DI / UDI-DI
- 45056030402362 FDA UDI
- FDA Product Code
- MED FDA UDI
- GMDN Term
- Lacrimal procedural cannula FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 880.6885 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Ethylene Oxide FDA UDI
Category: Lacrimal procedural cannula
Lachrymal Cannulae by Sterimedix Limited — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Lacrimal procedural cannula.
- Anodyne Surgical — Psi/Eye-Ko, Inc. · Class I
- AESCULAP — AESCULAP, INC. · Class I
- AESCULAP — AESCULAP, INC. · Class I
- Surgical Direct — SURGICAL DIRECT, INC. · Class I
- Surgical Direct — SURGICAL DIRECT, INC. · Class I
- AESCULAP — AESCULAP, INC. · Class I
- Surgical Direct — SURGICAL DIRECT, INC. · Class I
- Disposable Instruments — OASIS Medical, Inc. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Sterimedix Limited
Sources (1)
- FDA UDI b51bfb27-f8d0-4a40-9728-dca30da46d3d 34 fields · synced May 30, 2026